As of 2025-06-13, the EV/EBITDA ratio of Oncternal Therapeutics Inc (ONCT) is 0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ONCT's latest enterprise value is -11.52 mil USD. ONCT's TTM EBITDA according to its financial statements is -35.96 mil USD. Dividing these 2 quantities gives us the above ONCT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.6x - 14.1x | 13.8x |
| Forward P/E multiples | 17.9x - 32.2x | 20.6x |
| Fair Price | (213.28) - (166.63) | (204.53) |
| Upside | -40601.2% - -31742.5% | -38940.2% |
| Date | EV/EBITDA |